Veterinary Point Of Care Diagnostics Market would reach a staggering US$6.3 Billion in sales at a frightening 15.4% annual growth rate. by 2032 | FMI

Veterinary Point Of Care Diagnostics Market

The love for our furry companions is fueling a boom in veterinary medicine, particularly in the area of rapid diagnostics. A groundbreaking new report by Future Market Insights (FMI) reveals that the Veterinary Point Of Care Diagnostics Market is poised for a remarkable surge, with sales projected to reach nearly US$6.3 billion by 2032. This translates to a significant 15.4% Compound Annual Growth Rate (CAGR) – a substantial increase compared to historical growth patterns.

Key Driver: Companion Animal Healthcare on the Rise

FMI’s analysis highlights companion animals, particularly dogs, cats, and birds, as the primary drivers of this market growth. The increasing adoption of pets and rising disposable income allocated towards companion animal care are creating a strong demand for rapid and convenient diagnostic solutions. This trend is expected to present a potential revenue opportunity of nearly US$3.1 billion over the next decade, signifying a substantial market expansion.

Undoubtedly, the veterinary industry faced formidable challenges in the initial half of 2020, navigating the complexities introduced by government actions such as stay-at-home recommendations and social distancing procedures. Swift adaptation became imperative for market participants who responded by altering, reducing, or temporarily halting their operational activities. Veterinary clinics and hospitals reported lower patient volumes across various regions, with some establishments strategically focusing exclusively on emergency cases during this period.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14769

Owners of animals, on the other hand, continued to receive veterinary care because it was widely regarded as an “important” service. The blood/plasma/serum category, which accounted for more than 40.0 percent of total revenue, is expected to drive market growth. Regular blood testing is recommended by Kirkwood Animal Hospital in the United States as an important part of a companion animal’s overall wellness regimen. Blood tests are less expensive and less invasive than medical treatment.

Dogs and cats dominate the pet population in the United States, according to the American Pet Products Association’s National Pet Owners Survey for 2019 to 2020. (APPA). Americans are expected to spend more than $100 billion on pets by 2020. It is estimated that 31.4 billion US dollars were spent solely on veterinary care and product sales. According to the APPA survey, dog and cat owners spent an average of $426 and 214 on surgical vet visits, respectively, and 212 and 160 on routine vet visits.

Key Takeaways from the Veterinary Point Of Care Diagnostics Market Study

• The global veterinary point-of-care diagnostics market is expected to reach US$6.3 billion by 2032.
• North America is expected to contribute more than 30% of market revenue in 2022.
• Companion animals are expected to contribute the most revenue with a CAGR of 15.5%.
• The Consumables, Reagents, and Kits segment is expected to grow at the fastest rate, with a 15.8% CAGR.

Veterinary Point Of Care Diagnostics Market Competitive Landscape

This market is dominated by some regional and global players. Companies employ a variety of strategies to remain competitive.

• Heska Corp. announced the acquisition of Scil Animal Care Company GmbH, a provider of veterinary point-of-care diagnostics, in April 2020.
• IDEXX Laboratories announced the release of a canine Progesterone Test for the Catalyst One Chemistry and Catalyst Dx Analyzers in 2019.
• Fujifilm Sonosite announced a partnership with Partners Healthcare in 2019.
• Stablelab, a compact point-of-care blood test for horses, was introduced by Zoetis Inc. in 2019.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Global Veterinary Point Of Care Diagnostics Industry, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032. The study reveals essential insights based on end-users across five regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

Future Market Insights’ Domain Knowledge in Healthcare Division

Expert analysis, actionable insights, and strategic recommendations of the highly seasoned Healthcare domain team at Future Market Insights help clients from across the globe with their unique business intelligence needs. With a repertoire of over a thousand reports and 1 million-plus data points, the team has analyzed the Healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/14769

Segments Covered In Veterinary Point Of Care Diagnostics Market Analysis

By Animal Type:

• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Other Companion Animals
• Livestock Animals
  • Cattle
  • Swine
  • Poultry
  • Other Livestock Animals

By Product Type:

• Consumables, Reagents, & Kits
• Instruments & Devices

By Sample Type:

• Blood/Plasma/Serum
• Urine
• Fecal
• Other Sample Type

By Testing Type:

• Hematology
• Diagnostic Imaging
• Bacteriology
• Virology
• Cytology
• Clinical Chemistry
• Parasitology
• Serology
• Other Testing Type

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube